AstraZeneca's Covid vaccine linked to another fatal blood clotting disorder

New Delhi. NT Bureau: Researchers claim to have found a link between the AstraZeneca Covid-19 vaccine and a rare but fatal blood clotting disorder.

The disorder, vaccineinduced immune thrombocytopenia and thrombosis (VITT), has been associated with the AstraZeneca vaccine, says a study by Flinders University in Australia and other experts which found that the antibodies responsible for VITT share identical molecular fingerprints with those found in cases of adenoviral vector VITT.

AstraZeneca has acknowledged the rare side effects of its vaccine, including thrombotic thrombocytopenic syndrome (TTS), and has withdrawn marketing authorization from several global markets.

AstraZeneca's Covid-19 vaccine, known as Covishield in India, has been under scrutiny for its potential side effects.